Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Data-Driven Technologies are Shaking Up the Drug Development Process

Posted on March 1st, 2019 by in Pharma R&D

For many, many years, the findings of scientific research were published in an always-growing collection of scientific journals that spun off into more and more specialized disciplines. Today’s scientists have to think far beyond scholarly journals subscriptions and wrestle instead with search strategies and informatics.

(more…)

Three ways to reduce the cost of precision medicine

Posted on February 27th, 2019 by in Pharma R&D

In December 2018, the FDA announced it has formally recognized a public database containing genomic information, a huge milestone in the evolving field of precision medicine. Now researchers can use this information to validate their tests instead of having to generate their own data.

(more…)

When research gives you lemons – turning R&D failures into opportunities and success

Posted on February 25th, 2019 by in Pharma R&D

As highlighted in my colleague, Nicki Catchpole’s last post on accidental drug discovery, 90 Years of Penicillin, the landscape of R&D is littered with ‘failures’ that turned out to be vital innovations. Pharmaceutical R&D is no exception.

(more…)

AI in the life sciences – the good, the bad and the ugly

Posted on November 7th, 2018 by in Pharma R&D

Everyone in the life science industry – from the C-suite in the boardroom to scientists at the bench – are talking about the potential of AI, especially now they’re starting to see pharma companies using the technology. And we are beginning to see researchers mixing diverse kinds of data together – images, text and numeric data to name a few – to learn from. (more…)

  1. 1
  2. 2
  3. 3
  4. 5